News and Announcements

GSK shingles vaccine approved for expanded use in China

By Benjamin Chiou

Date: Tuesday 14 Oct 2025

(Sharecast News) - Pharma giant GSK has received regulatory approval in China to expand the use of its Shingrix shingles vaccine, the company announced on Tuesday.
Shingrix, which is currently available in China to adults over 50, has now been approved in adults 18 and over who are at increased risk...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page